FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Grant

Research Profile

Concepts & Ideas

Risk Factors

Disorders

Chemicals & Drugs

Physiology

Procedures

Case Control Studies

Anatomy

Thrombosis

Co-author Network

Publications

TOP 3
Madhu J Prasai; Peter J Grant; Mark T Kearney; Romana S Mughal; Stephen B Wheatcroft; Eleanor M Scott
Diurnal variation in vascular and metabolic function in diet-induced obesity: divergence of insulin resistance and loss of clock rhythm.
Kerrie A Smith; Søs Neergaard-Petersen; Richard J Pease; Helen Philippou; Peter J Adamson; Robert A S Ariëns; Craig A Avery; Jane M Brown; Esther J Cooke; Paul A Cordell; Colin W G Fishwick; Peter J Grant
The activation peptide cleft exposed by thrombin cleavage of FXIII-A(2) contains a recognition site for the fibrinogen α chain.
Victoria R Richardson; Verena Schroeder; Kristina Standeven; Peter J Grant; Angela M Carter
Complement C3 is a substrate for activated factor XIII that is cross-linked to fibrin during clot formation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Grant (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Madhu J Prasai; Peter J Grant; Mark T Kearney; Romana S Mughal; Stephen B Wheatcroft; Eleanor M Scott
Diurnal variation in vascular and metabolic function in diet-induced obesity: divergence of insulin resistance and loss of clock rhythm.
Diabetes 2013;62(6):1981-9.
2013: Kerrie A Smith; Søs Neergaard-Petersen; Richard J Pease; Helen Philippou; Peter J Adamson; Robert A S Ariëns; Craig A Avery; Jane M Brown; Esther J Cooke; Paul A Cordell; Colin W G Fishwick; Peter J Grant
The activation peptide cleft exposed by thrombin cleavage of FXIII-A(2) contains a recognition site for the fibrinogen α chain.
Blood 2013;121(11):2117-26.
2013: Victoria R Richardson; Verena Schroeder; Kristina Standeven; Peter J Grant; Angela M Carter
Complement C3 is a substrate for activated factor XIII that is cross-linked to fibrin during clot formation.
British journal of haematology 2013;160(1):116-9.
2012: Saad H Alzahrani; Robert A S Ariëns; Paul D Baxter; Richard Cubbon; T Gamlen; Peter J Grant; Katharina Hess; Fladia Phoenix; Jackie F Price; Mark Strachan; Ramzi A Ajjan
Gender-specific alterations in fibrin structure function in type 2 diabetes: associations with cardiometabolic and vascular markers.
The Journal of clinical endocrinology and metabolism 2012;97(12):E2282-7.
2012: Helen Imrie; Afroze Abbas; David J Beech; Keith M Channon; Richard M Cubbon; T Simon Futers; Matthew Gage; Stacey Galloway; V Kate Gatenby; Peter J Grant; Sheik Taqweer Rashid; Anna Skromna; Jessica Smith; Piruthivi Sukumar; Hema Viswambharan; Stephen B Wheatcroft; Shouhong Xuan; Nadira Yuldasheva; Mark T Kearney
Novel role of the IGF-1 receptor in endothelial function and repair: studies in endothelium-targeted IGF-1 receptor transgenic mice.
Diabetes 2012;61(9):2359-68.
2012: Adil Rajwani; Jaswinder K Sethi; Ajay M Shah; Jessica Smith; Piruthivi Sukumar; antonio vidal-puig; Hema Viswambharan; Afroze Abbas; Amir Aziz; Richard M Cubbon; Edward R Duncan; Vivienne Ezzat; Matthew Gage; Peter J Grant; Helen Imrie; Matthew B Kahn; Mark T Kearney; Karen E Porter; Shouhong Xuan; Nadira Y Yuldasheva; Stephen B Wheatcroft
Increasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosis.
Diabetes 2012;61(4):915-24.
2011: Amy L Cilia La Corte; Gillian I Rice; Guy A Rouleau; Albert Adam; Angela M Carter; Qing Ling Duan; Peter J Grant; Nigel M Hooper
A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor-induced angioedema.
Human mutation 2011;32(11):1326-31.
2011: Afroze Abbas; David J Beech; Keith M Channon; Richard M Cubbon; Matthew Gage; Stacey Galloway; Peter J Grant; Helen Imrie; Matthew Kahn; Adil Rajwani; Jessica Smith; Piruthivi Sukumar; Hema Viswambharan; Stephen B Wheatcroft; Shouhong Xuan; Nadira Yuldeshava; Mark T Kearney
The insulin-like growth factor-1 receptor is a negative regulator of nitric oxide bioavailability and insulin sensitivity in the endothelium.
Diabetes 2011;60(8):2169-78.
2011: Kristina Standeven; Anthony J Turner; Anthony J Balmforth; Angela M Carter; P A Cordell; K Hess; Nigel M Hooper; B Lu; Gillian I Rice; D J Scott; Peter J Grant
Neprilysin, obesity and the metabolic syndrome.
International journal of obesity (2005) 2011;35(8):1031-40.
2011: Shirley Uitte de Willige; Angela M Carter; Peter J Grant; Ton Lisman; Megan Miedzak; Helen Philippou; Frits R Rosendaal; Robert A S Ariëns
Proteolytic and genetic variation of the alpha-2-antiplasmin C-terminus in myocardial infarction.
Blood 2011;117(24):6694-701.
2011: Katharina Hess; Peter J Grant
Inflammation and thrombosis in diabetes.
Thrombosis and haemostasis 2011;105 Suppl 1():S43-54.
2011: Ramzi A Ajjan; Peter J Grant
The role of antiplatelets in hypertension and diabetes mellitus.
Journal of clinical hypertension (Greenwich, Conn.) 2011;13(4):305-13.
2011: Madhu J Prasai; Ida Pernicova; Peter J Grant; Eleanor M Scott
An endocrinologist's guide to the clock.
The Journal of clinical endocrinology and metabolism 2011;96(4):913-22.
2011: Kerrie A Smith; Peter J Adamson; Richard J Pease; Jane M Brown; Anthony J Balmforth; Paul A Cordell; Robert A S Ariëns; Helen Philippou; Peter J Grant
Interactions between factor XIII and the alphaC region of fibrinogen.
Blood 2011;117(12):3460-8.
2010: V Schroeder; Angela M Carter; J Dunne; M W Mansfield; Peter J Grant
Proinflammatory and hypofibrinolytic phenotype in healthy first-degree relatives of patients with Type 2 diabetes.
Journal of thrombosis and haemostasis : JTH 2010;8(9):2080-2.
2010: Paul A Cordell; Benjamin T Kile; Kristina Standeven; Emma C Josefsson; Richard J Pease; Peter J Grant
Association of coagulation factor XIII-A with Golgi proteins within monocyte-macrophages: implications for subcellular trafficking and secretion.
Blood 2010;115(13):2674-81.
2009: Helen Imrie; Afroze Abbas; Hema Viswambharan; Adil Rajwani; Richard M Cubbon; Matthew Gage; Matthew Kahn; Vivienne A Ezzat; Edward R Duncan; Peter J Grant; Ramzi Ajjan; Stephen B Wheatcroft; Mark T Kearney
Vascular insulin-like growth factor-I resistance and diet-induced obesity.
Endocrinology 2009;150(10):4575-82.
2009: Kristina F Standeven; Shirley Uitte de Willige; Angela M Carter; Peter J Grant
Heritability of clot formation.
Seminars in thrombosis and hemostasis 2009;35(5):458-67.
2009: Ramzi A Ajjan; Kristina Standeven; M Khanbhai; Fladia Phoenix; K C Gersh; John W Weisel; Mark T Kearney; Robert A S Ariëns; Peter J Grant
Effects of aspirin on clot structure and fibrinolysis using a novel in vitro cellular system.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(5):712-7.
2009: Neeraj Bhasin; Duncan J Parry; D Julian A Scott; Robert A S Ariëns; Peter J Grant; Robert M West
Regarding "Altered fibrin clot structure and function in individuals with intermittent claudication".
Journal of vascular surgery 2009;49(4):1088-9.
2009: Angela M Carter; Usha K Prasad; Peter J Grant
Complement C3 and C-reactive protein in male survivors of myocardial infarction.
Atherosclerosis 2009;203(2):538-43.
2009: Radwa H Abou-Saleh; Simon D Connell; Robert Harrand; Ramzi A Ajjan; Michael W Mosesson; D Alastair M Smith; Peter J Grant; Robert A S Ariëns
Nanoscale probing reveals that reduced stiffness of clots from fibrinogen lacking 42 N-terminal Bbeta-chain residues is due to the formation of abnormal oligomers.
Biophysical journal 2009;96(6):2415-27.
2009: Saran Shantikumar; Peter J Grant; Andrew J Catto; John M Bamford; Angela M Carter
Elevated C-reactive protein and long-term mortality after ischaemic stroke: relationship with markers of endothelial cell and platelet activation.
Stroke; a journal of cerebral circulation 2009;40(3):977-9.
2009: Peter J Grant
The EASD/ADA consensus: trick or treat?
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2009;6(1):5-6.
2008: Amy L Cilia La Corte; Angela M Carter; Anthony J Turner; Peter J Grant; Nigel M Hooper
The bradykinin-degrading aminopeptidase P is increased in women taking the oral contraceptive pill.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2008;9(4):221-5.
2008: Neeraj Bhasin; Robert A S Ariëns; Robert M West; Duncan J Parry; Peter J Grant; D Julian A Scott
Altered fibrin clot structure and function in the healthy first-degree relatives of subjects with intermittent claudication.
Journal of vascular surgery 2008;48(6):1497-503, 1503.e1.
2008: Eleanor M Scott; Angela M Carter; Peter J Grant
Diabetes and cardiovascular disease: related disorders created by disturbances in the endogenous clock.
Journal of the Indian Medical Association 2008;106(11):736-8, 740.
2008: R E Weaver; D Donnelly; M Wabitsch; Peter J Grant; Anthony J Balmforth
Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model.
International journal of obesity (2005) 2008;32(11):1705-11.
2008: Afroze Abbas; Peter J Grant; Mark T Kearney
Role of IGF-1 in glucose regulation and cardiovascular disease.
Expert review of cardiovascular therapy 2008;6(8):1135-49.
2008: Ramzi A Ajjan; Peter J Grant
The cardiovascular safety of rosiglitazone.
Expert opinion on drug safety 2008;7(4):367-76.
2008: Peter J Grant
The clock stopped, never to go again.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2008;5(2):75.
2008: Katie E Payne; Paul F Bray; Peter J Grant; Angela M Carter
Beta3 integrin haplotype influences gene regulation and plasma von Willebrand factor activity.
Atherosclerosis 2008;198(2):280-6.
2008: Kirti Kain; Angela M Carter; Peter J Grant; Eleanor M Scott
Alanine aminotransferase is associated with atherothrombotic risk factors in a British South Asian population.
Journal of thrombosis and haemostasis : JTH 2008;6(5):737-41.
2008: Barry I Hudson; Angela M Carter; Evis Harja; Kalea Anastasia; Maria Arriero; Hojin Yang; Peter J Grant; Ann Marie Schmidt
Identification, classification, and expression of RAGE gene splice variants.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(5):1572-80.
2008: Ramzi A Ajjan; R F Storey; Peter J Grant
Aspirin resistance and diabetes mellitus.
Diabetologia 2008;51(3):385-90.
2008: Richard M Cubbon; Chris Gale; Adil Rajwani; Afroze Abbas; Christine Morrell; Raj Das; Julian Barth; Peter J Grant; Mark T Kearney; Alistair Hall
Aspirin and mortality in patients with diabetes sustaining acute coronary syndrome.
Diabetes care 2008;31(2):363-5.
2008: Ramzi Ajjan; Bernard C B Lim; Kristina Standeven; Robert Harrand; Sarah Dolling; Fladia Phoenix; Richard Greaves; Radwa H Abou-Saleh; Simon Connell; D Alastair M Smith; John W Weisel; Peter J Grant; Robert A S Ariëns
Common variation in the C-terminal region of the fibrinogen beta-chain: effects on fibrin structure, fibrinolysis and clot rigidity.
Blood 2008;111(2):643-50.
2007: Emma R L C Vardy; Penny J Rice; Peter C W Bowie; John Holmes; Peter J Grant; Nigel M Hooper
Increased circulating insulin-like growth factor-1 in late-onset Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2007;12(4):285-90.
2007: Angela M Carter; Charlotte M Cymbalista; Tim D Spector; Peter J Grant
Heritability of clot formation, morphology, and lysis: the EuroCLOT study.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(12):2783-9.
2007: Richard M Cubbon; Adil Rajwani; Afroze Abbas; Chris Gale; Peter J Grant; Stephen B Wheatcroft; Julian Barth; Mark T Kearney; Alistair Hall
Hyperglycaemia, in relation to sex, and mortality after acute coronary syndrome.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2007;14(5):666-71.
2007: Richard M Cubbon; Chris Gale; Peter J Grant; Alistair Hall; Mark T Kearney
Lower rates of heart failure and death in acute coronary syndromes.
JAMA : the journal of the American Medical Association 2007;298(9):969; author reply 970-1.
2007: Peter J Grant
Diabetes mellitus as a prothrombotic condition.
Journal of internal medicine 2007;262(2):157-72.
2007: Kristina Standeven; Angela M Carter; Peter J Grant; John W Weisel; Irina N Chernysh; Leona Masova; Susan T Lord; Robert A S Ariëns
Functional analysis of fibrin {gamma}-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness.
Blood 2007;110(3):902-7.
2007: Peter J Grant
Rosiglitazone and cardiovascular disease: a diabetologist's perspective.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2007;4(2):75-6.
2007: Angela M Carter; Andrew J Catto; Michael W Mansfield; John M Bamford; Peter J Grant
Predictive variables for mortality after acute ischemic stroke.
Stroke; a journal of cerebral circulation 2007;38(6):1873-80.
2007: Ramzi A Ajjan; Angela M Carter; R Somani; Kirti Kain; Peter J Grant
Ethnic differences in cardiovascular risk factors in healthy Caucasian and South Asian individuals with the metabolic syndrome.
Journal of thrombosis and haemostasis : JTH 2007;5(4):754-60.
2007: Anthony J Balmforth; Peter J Grant; Eleanor M Scott; Stephen B Wheatcroft; Mark T Kearney; Bart Staels; Nikolaus Marx
Inter-subject differences in constitutive expression levels of the clock gene in man.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2007;4(1):39-43.
2007: Richard M Cubbon; Stephen B Wheatcroft; Peter J Grant; Chris Gale; Julian Barth; Robert J Sapsford; Ramzi A Ajjan; Mark T Kearney; Alistair Hall
Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003.
European heart journal 2007;28(5):540-5.
2006: Ramzi A Ajjan; Peter J Grant
Cardiovascular disease prevention in patients with type 2 diabetes: The role of oral anti-diabetic agents.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2006;3(3):147-58.
2006: Gillian I Rice; Amy L Jones; Peter J Grant; Angela M Carter; Anthony J Turner; Nigel M Hooper
Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study.
Hypertension 2006;48(5):914-20.
2006: Riyaz Somani; Peter J Grant; Kirti Kain; Andrew J Catto; Angela M Carter
Complement C3 and C-reactive protein are elevated in South Asians independent of a family history of stroke.
Stroke; a journal of cerebral circulation 2006;37(8):2001-6.
2006: Marlies de Lange; Toby Andrew; Harold Snieder; Dongliang Ge; T Simon Futers; Kristina Standeven; Tim D Spector; Peter J Grant; Robert A S Ariëns
Joint linkage and association of six single-nucleotide polymorphisms in the factor XIII-A subunit gene point to V34L as the main functional locus.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(8):1914-9.
2006: E M Scott; Peter J Grant
Neel revisited: the adipocyte, seasonality and type 2 diabetes.
Diabetologia 2006;49(7):1462-6.
2006: Ramzi A Ajjan; Peter J Grant
Coagulation and atherothrombotic disease.
Atherosclerosis 2006;186(2):240-59.
2006: Emma J Dunn; Helen Philippou; Robert A S Ariëns; Peter J Grant
Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus.
Diabetologia 2006;49(5):1071-80.
2006: Ramzi A Ajjan; Peter J Grant; Timothy S Futers; Jane M Brown; Angela M Carter
The association of complement C3 genotype with coronary artery disease, markers of the metabolic syndrome and C3 plasma levels.
Thrombosis and haemostasis 2006;95(2):393-4.
2005: Ramzi A Ajjan; Peter J Grant; Timothy S Futers; Jane M Brown; Charlotte M Cymbalista; May Boothby; Angela M Carter
Complement C3 and C-reactive protein levels in patients with stable coronary artery disease.
Thrombosis and haemostasis 2005;94(5):1048-53.
2005: Ramzi A Ajjan; Peter J Grant
Role of clotting factors and fibrin structure in predisposition to atherothrombotic disease.
Expert review of cardiovascular therapy 2005;3(6):1047-59.
2005: Angela M Carter; C E Bennett; J A Bostock; Peter J Grant
Metformin reduces C-reactive protein but not complement factor C3 in overweight patients with Type 2 diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 2005;22(9):1282-4.
2005: Kristina Standeven; Robert A S Ariëns; Peter J Grant
The molecular physiology and pathology of fibrin structure/function.
Blood reviews 2005;19(5):275-88.
2005: Peter J Grant
The adipocyte speaks: are we listening?
Journal of thrombosis and haemostasis : JTH 2005;3(6):1172-3.
2005: Emma J Dunn; Robert A S Ariëns; Peter J Grant
The influence of type 2 diabetes on fibrin structure and function.
Diabetologia 2005;48(6):1198-206.
2005: Emma J Dunn; Peter J Grant
Type 2 diabetes: an atherothrombotic syndrome.
Current molecular medicine 2005;5(3):323-32.
2005: Clair M Sullivan; T Simon Futers; Jennifer H Barrett; Barry I Hudson; Mark S Freeman; Peter J Grant
RAGE polymorphisms and the heritability of insulin resistance: the Leeds family study.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2005;2(1):42-4.
2004: Chris Gale; Peter J Grant
The characterisation and functional analysis of the human glyoxalase-1 gene using methods of bioinformatics.
Gene 2004;340(2):251-60.
2004: Gillian I Rice; Daniel A Thomas; Peter J Grant; Anthony J Turner; Nigel M Hooper
Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.
The Biochemical journal 2004;383(Pt 1):45-51.
2004: Eleanor M Scott; Robert A S Ariëns; Peter J Grant
Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(9):1558-66.
2004: Paul A Cordell; T Simon Futers; Peter J Grant; Richard J Pease
The Human hydroxyacylglutathione hydrolase (HAGH) gene encodes both cytosolic and mitochondrial forms of glyoxalase II.
The Journal of biological chemistry 2004;279(27):28653-61.
2004: Peter J Grant
Is hypercoagulability an issue in arterial thrombosis? Yes.
Journal of thrombosis and haemostasis : JTH 2004;2(5):690-1.
2004: Emma J Dunn; Robert A S Ariëns; Marlies de Lange; Harold Snieder; John H Turney; Tim D Spector; Peter J Grant
Genetics of fibrin clot structure: a twin study.
Blood 2004;103(5):1735-40.
2003: Peter J Grant
Beneficial effects of metformin on haemostasis and vascular function in man.
Diabetes & metabolism 2003;29(4 Pt 2):6S44-52.
2003: Helen Philippou; James B Rance; Timothy Myles; Scott W Hall; Robert A Ariens; Peter J Grant; Lawrence Leung; David A Lane
Roles of low specificity and cofactor interaction sites on thrombin during factor XIII activation. Competition for cofactor sites on thrombin determines its fate.
The Journal of biological chemistry 2003;278(34):32020-6.
2003: Angela M Carter; K Anagnostopoulou; M W Mansfield; Peter J Grant
Soluble P-selectin levels, P-selectin polymorphisms and cardiovascular disease.
Journal of thrombosis and haemostasis : JTH 2003;1(8):1718-23.
2003: K Kain; Andrew J Catto; Peter J Grant
Associations between insulin resistance and thrombotic risk factors in high-risk South Asian subjects.
Diabetic medicine : a journal of the British Diabetic Association 2003;20(8):651-5.
2003: Peter J Grant
The genetics of atherothrombotic disorders: a clinician's view.
Journal of thrombosis and haemostasis : JTH 2003;1(7):1381-90.
2003: Kristina Standeven; Peter J Grant; Angela M Carter; Tomas Scheiner; John W Weisel; Robert A S Ariëns
Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function.
Circulation 2003;107(18):2326-30.
2003: Bernard C B Lim; Robert A S Ariëns; Angela M Carter; John W Weisel; Peter J Grant
Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk.
Lancet 2003;361(9367):1424-31.
2003: Marlies de Lange; Harold Snieder; Robert A S Ariëns; Toby Andrew; Peter J Grant; Tim D Spector
The relation between insulin resistance and hemostasis: pleiotropic genes and common environment.
Twin research : the official journal of the International Society for Twin Studies 2003;6(2):152-61.
2003: Julian P Winter; YunYun Gong; Peter J Grant; Christopher P Wild
Glutathione peroxidase 1 genotype is associated with an increased risk of coronary artery disease.
Coronary artery disease 2003;14(2):149-53.
2003: K Kain; Angela M Carter; John M Bamford; Peter J Grant; Andrew J Catto
Gender differences in coagulation and fibrinolysis in white subjects with acute ischemic stroke.
Journal of thrombosis and haemostasis : JTH 2003;1(2):390-2.
2003: Mark S Freeman; Michael W Mansfield; Jennifer H Barrett; Peter J Grant
Insulin resistance: an atherothrombotic syndrome. The Leeds family study.
Thrombosis and haemostasis 2003;89(1):161-8.
2003: Michael H Wilson; Peter J Grant; Kirti Kain; Darren P Warner; Christopher P Wild
Association between the risk of coronary artery disease in South Asians and a deletion polymorphism in glutathione S-transferase M1.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2003;8(1):43-50.
2002: Mark S Freeman; Michael W Mansfield; Jennifer H Barrett; Peter J Grant
Heritability of features of the insulin resistance syndrome in a community-based study of healthy families.
Diabetic medicine : a journal of the British Diabetic Association 2002;19(12):994-9.
2002: Kirti Kain; Andrew J Catto; John Young; John Bamford; John Bavington; Peter J Grant
Coagulation factor VII activity, Arg/Gln353 polymorphism and features of insulin resistance in first-degree-relatives of South Asian patients with stroke.
Thrombosis and haemostasis 2002;88(6):954-60.
2002: Kirti Kain; Andrew J Catto; Peter J Grant
Clustering of thrombotic factors with insulin resistance in South Asian patients with ischaemic stroke.
Thrombosis and haemostasis 2002;88(6):950-3.
2002: Joseph D Mills; Robert A S Ariëns; Michael W Mansfield; Peter J Grant
Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease.
Circulation 2002;106(15):1938-42.
2002: Chris Gale; Peter J Grant
Atherothrombotic disease and factor XIII: lucky for some?
European journal of clinical investigation 2002;32(9):637-9.
2002: Hans P Kohler; Robert A S Ariëns; Andrew J Catto; Angela M Carter; George J Miller; Jackie A Cooper; Michael W Mansfield; Kristina Standeven; Peter J Grant
Factor XIII A-subunit concentration predicts outcome in stroke subjects and vascular outcome in healthy, middle-aged men.
British journal of haematology 2002;118(3):825-32.
2002: Robert A S Ariëns; Thung Lai; John W Weisel; Charles S Greenberg; Peter J Grant
Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms.
Blood 2002;100(3):743-54.
2002: Kirti Kain; Andrew J Catto; John Young; John Bamford; John Bavington; Peter J Grant
Increased fibrinogen, von Willebrand factor and tissue plasminogen activator levels in insulin resistant South Asian patients with ischaemic stroke.
Atherosclerosis 2002;163(2):371-6.
2002: Kirti Kain; Jonathan M Blaxill; Andrew J Catto; Peter J Grant; Angela M Carter
Increased fibrinogen levels among South Asians versus Whites in the United Kingdom are not explained by common polymorphisms.
American journal of epidemiology 2002;156(2):174-9.
2002: Joseph D Mills; Michael W Mansfield; Peter J Grant
Tissue plasminogen activator, fibrin D-dimer, and insulin resistance in the relatives of patients with premature coronary artery disease.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(4):704-9.
2002: Mumtaz Hayat; Robert A S Ariëns; Paul Moayyedi; Peter J Grant; Seamus O'Mahony
Coagulation factor XIII and markers of thrombin generation and fibrinolysis in patients with inflammatory bowel disease.
European journal of gastroenterology & hepatology 2002;14(3):249-56.
2002: Joseph D Mills; Michael W Mansfield; Peter J Grant
Factor XIII-circulating levels and the Val34Leu polymorphism in the healthy male relatives of patients with severe coronary artery disease.
Thrombosis and haemostasis 2002;87(3):409-14.
2002: Mark S Freeman; Michael W Mansfield; Jennifer H Barrett; Peter J Grant
Genetic contribution to circulating levels of hemostatic factors in healthy families with effects of known genetic polymorphisms on heritability.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(3):506-10.
2002: Robert A S Ariëns; Marlies de Lange; Harold Snieder; May Boothby; Tim D Spector; Peter J Grant
Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state.
Lancet 2002;359(9307):667-71.
2002: Alastair J Lansbury; Peter J Grant; Andrew J Catto
Atherothrombotic risk factors in subjects with a family history of stroke.
Cerebrovascular diseases (Basel, Switzerland) 2002;14(3-4):153-60.
2002: Kirti Kain; John Young; John Bamford; John Bavington; Peter J Grant; Andrew J Catto
Determinants of plasminogen activator inhibitor-1 in South Asians with ischaemic stroke.
Cerebrovascular diseases (Basel, Switzerland) 2002;14(2):77-83.
2002: Kristina Standeven; Robert A S Ariëns; Paul Whitaker; Alison E Ashcroft; John W Weisel; Peter J Grant
The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation.
Diabetes 2002;51(1):189-97.
2001: Barry I Hudson; MH Stickland; Peter J Grant; T Simon Futers
Characterization of allelic and nucleotide variation between the RAGE gene on chromosome 6 and a homologous pseudogene sequence to its 5' regulatory region on chromosome 3: implications for polymorphic studies in diabetes.
Diabetes 2001;50(12):2646-51.
2001: Barry I Hudson; MH Stickland; T Simon Futers; Peter J Grant
Study of the -429 T/C and -374 T/A receptor for advanced glycation end products promoter polymorphisms in diabetic and nondiabetic subjects with macrovascular disease.
Diabetes care 2001;24(11):2004.
2001: D Warner; Michael W Mansfield; Peter J Grant
Coagulation factor XIII levels in UK Asian subjects with type 2 diabetes mellitus and coronary artery disease.
Thrombosis and haemostasis 2001;86(4):1117-8.
2001: Kirti Kain; Andrew J Catto; Angela M Carter; John Young; John Bamford; John Bavington; Peter J Grant
Decreased fibrinolytic potential in South Asian women with ischaemic cerebrovascular disease.
British journal of haematology 2001;114(1):155-61.
2001: Kirti Kain; Andrew J Catto; Peter J Grant
Impaired fibrinolysis and increased fibrinogen levels in South Asian subjects.
Atherosclerosis 2001;156(2):457-61.
2001: Barry I Hudson; MH Stickland; T Simon Futers; Peter J Grant
Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy.
Diabetes 2001;50(6):1505-11.
2001: A Amini-Nekoo; T Simon Futers; Marco Moia; P M Mannucci; Peter J Grant; Robert A S Ariëns
Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis.
British journal of haematology 2001;113(2):537-43.
2001: Kirti Kain; Andrew J Catto; John Young; John Bamford; John Bavington; Peter J Grant
Insulin resistance and elevated levels of tissue plasminogen activator in first-degree relatives of South Asian patients with ischemic cerebrovascular disease.
Stroke; a journal of cerebral circulation 2001;32(5):1069-73.
2001: Hans P Kohler; Robert A S Ariëns; Michael W Mansfield; Paul Whitaker; Peter J Grant
Factor XIII activity and antigen levels in patients with coronary artery disease.
Thrombosis and haemostasis 2001;85(3):569-70.
2001: D Warner; Michael W Mansfield; Peter J Grant
Coagulation factor XIII and cardiovascular disease in UK Asian patients undergoing coronary angiography.
Thrombosis and haemostasis 2001;85(3):408-11.
2001: Marlies de Lange; Harold Snieder; Robert A S Ariëns; Tim D Spector; Peter J Grant
The genetics of haemostasis: a twin study.
Lancet 2001;357(9250):101-5.
2000: D Warner; Andrew J Catto; G Kunz; HA Ireland; Peter J Grant; David A Lane
The thrombomodulin gene mutation G(127)-->A (Ala25Thr) and cerebrovascular disease.
Cerebrovascular diseases (Basel, Switzerland) 2000;10(5):359-63.
2000: Angela M Carter; Andrew J Catto; Hans P Kohler; Robert A S Ariëns; MH Stickland; Peter J Grant
alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism.
Blood 2000;96(3):1177-9.
2000: Robert A S Ariëns; Helen Philippou; Chandrasekaran Nagaswami; John W Weisel; David A Lane; Peter J Grant
The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure.
Blood 2000;96(3):988-95.
2000: Andrew J Catto; L J McCormack; Michael W Mansfield; Angela M Carter; John M Bamford; P Robinson; Peter J Grant
Apolipoprotein E polymorphism in cerebrovascular disease.
Acta neurologica Scandinavica 2000;101(6):399-404.
2000: Michael W Mansfield; Hans P Kohler; Robert A S Ariëns; L J McCormack; Peter J Grant
Circulating levels of coagulation factor XIII in subjects with type 2 diabetes and in their first-degree relatives.
Diabetes care 2000;23(5):703-5.
2000: David A Lane; Peter J Grant
Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease.
Blood 2000;95(5):1517-32.
2000: Alison E Ashcroft; Peter J Grant; Robert A S Ariëns
A study of human coagulation factor XIII A-subunit by electrospray ionisation mass spectrometry.
Rapid communications in mass spectrometry : RCM 2000;14(17):1607-11.
1999: Angela M Carter; Andrew J Catto; John M Bamford; Peter J Grant
Association of the platelet glycoprotein IIb HPA-3 polymorphism with survival after acute ischemic stroke.
Stroke; a journal of cerebral circulation 1999;30(12):2606-11.
1999: Peter J Grant; S E Humphries
Genetic determinants of arterial thrombosis.
Baillière's best practice & research. Clinical haematology 1999;12(3):505-32.
1999: Hans P Kohler; Michael W Mansfield; P S Clark; Peter J Grant
Interaction between insulin resistance and factor XIII Val34Leu in patients with coronary artery disease.
Thrombosis and haemostasis 1999;82(3):1202-3.
1999: Robert A S Ariëns; Hans P Kohler; Michael W Mansfield; Peter J Grant
Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking, and hypertension.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(8):2012-6.
1999: Angela M Carter; Andrew J Catto; Peter J Grant
Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation.
Circulation 1999;99(18):2423-6.
1999: Hans P Kohler; T S Futers; Peter J Grant
FXII (46C-->T) polymorphism and in vivo generation of FXII activity--gene frequencies and relationship in patients with coronary artery disease.
Thrombosis and haemostasis 1999;81(5):745-7.
1999: Hans P Kohler; T S Futers; Peter J Grant
Prevalence of three common polymorphisms in the A-subunit gene of factor XIII in patients with coronary artery disease.
Thrombosis and haemostasis 1999;81(4):511-5.
1999: Gillian I Rice; CA Foy; Peter J Grant
Angiotensin converting enzyme and angiotensin II type 1-receptor gene polymorphisms and risk of ischaemic heart disease.
Cardiovascular research 1999;41(3):746-53.
1999: Hans P Kohler; Peter J Grant
The role of factor XIIIVal34Leu in cardiovascular disease.
QJM : monthly journal of the Association of Physicians 1999;92(2):67-72.
1999: Andrew J Catto; Hans P Kohler; J Coore; Michael W Mansfield; MH Stickland; Peter J Grant
Association of a common polymorphism in the factor XIII gene with venous thrombosis.
Blood 1999;93(3):906-8.
1998: N Salooja; A Catto; A Carter; E G Tudenham; Peter J Grant
Methylene tetrahydrofolate reductase C677T genotype and stroke.
Clinical and laboratory haematology 1998;20(6):357-61.
1998: L J McCormack; J I Semple; MH Stickland; J H Barrett; Peter J Grant
The effect of number of days in culture and plasminogen activator inhibitor-1 (PAI-1) 4G/5G genotype on PAI-1 antigen release by cultured human umbilical vein endothelial cells.
Thrombosis research 1998;92(5):199-206.
1998: Gillian I Rice; Peter J Grant
FVIII coagulant activity and antigen in subjects with ischaemic heart disease.
Thrombosis and haemostasis 1998;80(5):757-62.
1998: Michael W Mansfield; Andrew J Catto; Angela M Carter; Peter J Grant
Fibrinolytic measurements in type 2 diabetic patients with acute cerebral infarction.
Diabetic medicine : a journal of the British Diabetic Association 1998;15(11):953-7.
1998: Hans P Kohler; Robert A S Ariëns; Paul Whitaker; Peter J Grant
A common coding polymorphism in the FXIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity.
Thrombosis and haemostasis 1998;80(4):704.
1998: Angela M Carter; Andrew J Catto; Peter J Grant
Determinants of tPA antigen and associations with coronary artery disease and acute cerebrovascular disease.
Thrombosis and haemostasis 1998;80(4):632-6.
1998: L J McCormack; K Kain; Andrew J Catto; Hans P Kohler; MH Stickland; Peter J Grant
Prevalence of FXIII V34L in populations with different cardiovascular risk.
Thrombosis and haemostasis 1998;80(3):523-4.
1998: Angela M Carter; Andrew J Catto; John M Bamford; Peter J Grant
Platelet GP IIIa PlA and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(7):1124-31.
1998: Barry I Hudson; MH Stickland; Peter J Grant
Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups.
Diabetes 1998;47(7):1155-7.
1998: Dinesh Nagi; CA Foy; Vidya Mohamed-Ali; John S Yudkin; Peter J Grant; William C Knowler
Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indians.
Metabolism: clinical and experimental 1998;47(5):622-6.
1998: Angela M Carter; Michael W Mansfield; Peter J Grant
Polymorphisms of platelet glycoproteins in relation to macrovascular disease in type 2 diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 1998;15(4):315-9.
1998: N Ossei-Gerning; IJ Wilson; Peter J Grant
Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease.
Thrombosis and haemostasis 1998;79(4):736-40.
1998: Andrew J Catto; Hans P Kohler; S Bannan; MH Stickland; A Carter; Peter J Grant
Factor XIII Val 34 Leu: a novel association with primary intracerebral hemorrhage.
Stroke; a journal of cerebral circulation 1998;29(4):813-6.
1998: Hans P Kohler; Angela M Carter; MH Stickland; Peter J Grant
Levels of activated FXII in survivors of myocardial infarction--association with circulating risk factors and extent of coronary artery disease.
Thrombosis and haemostasis 1998;79(1):14-8.
1998: Hans P Kohler; MH Stickland; N Ossei-Gerning; A Carter; H Mikkola; Peter J Grant
Association of a common polymorphism in the factor XIII gene with myocardial infarction.
Thrombosis and haemostasis 1998;79(1):8-13.
1997: Gillian I Rice; N Ossei-Gerning; MH Stickland; Peter J Grant
The paraoxonase Gln-Arg 192 polymorphism in subjects with ischaemic heart disease.
Coronary artery disease 1997;8(11-12):677-82.
1997: Peter J Grant
Polymorphisms of coagulation/fibrinolysis genes: gene environment interactions and vascular risk.
Prostaglandins, leukotrienes, and essential fatty acids 1997;57(4-5):473-7.
1997: Angela M Carter; N Ossei-Gerning; IJ Wilson; Peter J Grant
Association of the platelet Pl(A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease.
Circulation 1997;96(5):1424-31.
1997: CA Foy; Gillian I Rice; N Ossei-Gerning; Michael W Mansfield; Peter J Grant
Angiotensin-converting enzyme (ACE) gene polymorphisms in patients characterised by coronary angiography.
Human genetics 1997;100(3-4):420-5.
1997: H P Kohler; M Boothby; L McCormack; William C Knowler; Peter J Grant
Incidence of Arg506 --> Gln mutation (factor V Leiden) in Pima Indians.
Thrombosis and haemostasis 1997;78(2):961-2.
1997: Dinesh Nagi; L J McCormack; Vidya Mohamed-Ali; John S Yudkin; William C Knowler; Peter J Grant
Diabetic retinopathy, promoter (4G/5G) polymorphism of PAI-1 gene, and PAI-1 activity in Pima Indians with type 2 diabetes.
Diabetes care 1997;20(8):1304-9.
1997: N Ossei-Gerning; Paul Moayyedi; S Smith; David Braunholtz; J I Wilson; A T Axon; Peter J Grant
Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography.
Cardiovascular research 1997;35(1):120-4.
1997: Andrew J Catto; Angela M Carter; J H Barrett; John Bamford; P J Rice; Peter J Grant
von Willebrand factor and factor VIII: C in acute cerebrovascular disease. Relationship to stroke subtype and mortality.
Thrombosis and haemostasis 1997;77(6):1104-8.
1997: N Ossei-Gerning; Michael W Mansfield; MH Stickland; Peter J Grant
Insulin receptor substrate-1 gene polymorphism and cardiovascular risk in non-insulin dependent diabetes mellitus and patients undergoing coronary angiography.
Clinical and laboratory haematology 1997;19(2):123-8.
1997: Angela M Carter; Peter J Grant
Vascular homeostasis, adhesion molecules, and macrovascular disease in non-insulin-dependent diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 1997;14(6):423-32.
1997: CA Foy; Peter J Grant
PCR-RFLP detection of PAI-2 gene variants: prevalence in ethnic groups and disease relationship in patients undergoing coronary angiography.
Thrombosis and haemostasis 1997;77(5):955-8.
1997: Andrew J Catto; Angela M Carter; MH Stickland; John M Bamford; J A Davies; Peter J Grant
Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease.
Thrombosis and haemostasis 1997;77(4):730-4.
1997: D M Heywood; Angela M Carter; Andrew J Catto; John M Bamford; Peter J Grant
Polymorphisms of the factor VII gene and circulating FVII:C levels in relation to acute cerebrovascular disease and poststroke mortality.
Stroke; a journal of cerebral circulation 1997;28(4):816-21.
1997: Angela M Carter; Andrew J Catto; John M Bamford; Peter J Grant
Gender-specific associations of the fibrinogen B beta 448 polymorphism, fibrinogen levels, and acute cerebrovascular disease.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(3):589-94.
1997: Michael W Mansfield; MH Stickland; Peter J Grant
PAI-1 concentrations in first-degree relatives of patients with non-insulin-dependent diabetes: metabolic and genetic associations.
Thrombosis and haemostasis 1997;77(2):357-61.
1997: N Ossei-Gerning; Michael W Mansfield; MH Stickland; IJ Wilson; Peter J Grant
Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(1):33-7.
1996: L J McCormack; Dinesh Nagi; MH Stickland; Michael W Mansfield; Vidya Mohamed-Ali; John S Yudkin; William C Knowler; Peter J Grant
Promoter (4G/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome.
Diabetologia 1996;39(12):1512-8.
1996: Angela M Carter; Michael W Mansfield; MH Stickland; Peter J Grant
Beta-fibrinogen gene-455 G/A polymorphism and fibrinogen levels. Risk factors for coronary artery disease in subjects with NIDDM.
Diabetes care 1996;19(11):1265-8.
1996: Michael W Mansfield; D M Heywood; Peter J Grant
Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM.
Circulation 1996;94(9):2171-6.
1996: D M Heywood; N Ossei-Gerning; Peter J Grant
Association of factor VII:C levels with environmental and genetic factors in patients with ischaemic heart disease and coronary atheroma characterised by angiography.
Thrombosis and haemostasis 1996;76(2):161-5.
1996: D M Heywood; Michael W Mansfield; Peter J Grant
Levels of von Willebrand factor, insulin resistance syndrome, and a common vWF gene polymorphism in non-insulin-dependent (type 2) diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 1996;13(8):720-5.
1996: C A Foy; L J McCormack; William C Knowler; Jennifer H Barrett; Andrew J Catto; Peter J Grant
The angiotensin-I converting enzyme (ACE) gene I/D polymorphism and ACE levels in Pima Indians.
Journal of medical genetics 1996;33(4):336-7.
1996: Angela M Carter; Paul Moayyedi; Andrew J Catto; R M Heppell; A T R Axon; Peter J Grant
The influence of Helicobacter pylori status on circulating levels of the coagulation factors fibrinogen, von Willebrand factor, factor VII, and factor VIII.
Helicobacter 1996;1(1):65-9.
1996: D M Heywood; Michael W Mansfield; Peter J Grant
Factor VII gene polymorphisms, factor VII:C levels and features of insulin resistance in non-insulin-dependent diabetes mellitus.
Thrombosis and haemostasis 1996;75(3):401-6.
1996: Andrew J Catto; Angela M Carter; Jennifer H Barrett; MH Stickland; J Bamford; J A Davies; Peter J Grant
Angiotensin-converting enzyme insertion/deletion polymorphism and cerebrovascular disease.
Stroke; a journal of cerebral circulation 1996;27(3):435-40.
1996: Jennifer H Barrett; C A Foy; Peter J Grant
Commingling analysis of the distribution of a phenotype conditioned on two marker genotypes: application to plasma angiotensin-converting enzyme levels.
Genetic epidemiology 1996;13(6):615-25.
1996: Peter J Grant
The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetes.
Diabetes care 1996;19(1):64-6.
1996: Michael W Mansfield; D M Heywood; Peter J Grant
Sex differences in coagulation and fibrinolysis in white subjects with non-insulin-dependent diabetes mellitus.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(1):160-4.
1995: Michael W Mansfield; Peter J Grant
Fibrinolysis and diabetic retinopathy in NIDDM.
Diabetes care 1995;18(12):1577-81.
1995: Dinesh Nagi; Michael W Mansfield; MH Stickland; Peter J Grant
Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism, and diabetic retinopathy in subjects with IDDM and NIDDM.
Diabetic medicine : a journal of the British Diabetic Association 1995;12(11):997-1001.
1995: Michael W Mansfield; MH Stickland; Peter J Grant
Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes.
Thrombosis and haemostasis 1995;74(4):1032-4.
1995: Michael W Mansfield; MH Stickland; Peter J Grant
Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with non-insulin-dependent diabetes mellitus.
Thrombosis and haemostasis 1995;74(3):842-7.
1995: Peter J Grant
The effects of metformin on cardiovascular risk factors.
Diabetes/metabolism reviews 1995;11 Suppl 1():S43-50.
1995: A J Catto; Peter J Grant
Risk factors for cerebrovascular disease and the role of coagulation and fibrinolysis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1995;6(6):497-510.
1995: S C Gough; J Smyllie; M Barker; K E Berkin; P J Rice; Peter J Grant
Diastolic dysfunction is not related to changes in glycaemic control over 6 months in type 2 (non-insulin-dependent) diabetes mellitus. A cross-sectional study.
Acta diabetologica 1995;32(2):110-5.
1994: C A Foy; P Quirke; D J Williams; F A Lewis; Peter J Grant; R Eglin; H Jonathan Bodansky
A search for candidate viruses in type 1 diabetic pancreas using the polymerase chain reaction.
Diabetic medicine : a journal of the British Diabetic Association 1994;11(6):564-9.
1994: Michael W Mansfield; MH Stickland; Angela M Carter; Peter J Grant
Polymorphisms of the plasminogen activator inhibitor-1 gene in type 1 and type 2 diabetes, and in patients with diabetic retinopathy.
Thrombosis and haemostasis 1994;71(6):731-6.
1993: S J Padayatty; SM Orme; P D Zenobi; M H Stickland; Paul E Belchetz; Peter J Grant
The effects of insulin-like growth factor-1 on plasminogen activator inhibitor-1 synthesis and secretion: results from in vitro and in vivo studies.
Thrombosis and haemostasis 1993;70(6):1009-13.
1993: S C Gough; P J Rice; L McCormack; C Chapman; Peter J Grant
The relationship between plasminogen activator inhibitor-1 and insulin resistance in newly diagnosed type 2 diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 1993;10(7):638-42.
1993: S H Ibbotson; S C Gough; P J Rice; J A Davies; Peter J Grant
The effect of short-term exercise on plasma procoagulant activity in patients with type II (non-insulin-dependent) diabetes and healthy volunteers.
Thrombosis research 1993;71(2):149-58.
1993: S H Ibbotson; H Rayner; MH Stickland; J A Davies; Peter J Grant
Thrombin generation and factor VIII:C levels in patients with type 1 diabetes complicated by nephropathy.
Diabetic medicine : a journal of the British Diabetic Association 1993;10(4):336-40.
1993: C R Prentice; K K Hampton; Peter J Grant; S R Nelson; W Nieuwenhuizen; P J Gaffney
The fibrinolytic response to ancrod therapy: characterization of fibrinogen and fibrin degradation products.
British journal of haematology 1993;83(2):276-81.
1992: SM Orme; J P Sebastian; Brian Oldroyd; SP Stewart; Peter J Grant; M H Stickland; M A Smith; Paul E Belchetz
Comparison of measures of body composition in a trial of low dose growth hormone replacement therapy.
Clinical endocrinology 1992;37(5):453-9.
1992: S C Gough; J Smyllie; T Sheldon; P J Rice; Peter J Grant
The anatomical distribution of plasma fibrinolytic activity in man during cardiac catheterisation.
Thrombosis and haemostasis 1992;68(4):442-7.
1992: S H Ibbotson; D Walmsley; J A Davies; Peter J Grant
Generation of thrombin activity in relation to factor VIII:C concentrations and vascular complications in type 1 (insulin-dependent) diabetes mellitus.
Diabetologia 1992;35(9):863-7.
1992: S H Ibbotson; J A Davies; Peter J Grant
The influence of infusions of 1-desamino-8-D-arginine vasopressin (DDAVP) in vivo on thrombin generation in vitro.
Thrombosis and haemostasis 1992;68(1):37-9.
1992: S C Gough; S Whitworth; P J Rice; Peter J Grant
The effect of exercise and heart rate on fibrinolytic activity.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1992;3(2):179-82.
1991: D Walmsley; K K Hampton; Peter J Grant
Contrasting fibrinolytic responses in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes.
Diabetic medicine : a journal of the British Diabetic Association 1991;8(10):954-9.
1991: S C Gough; Peter J Grant
The fibrinolytic system in diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 1991;8(10):898-905.
1991: K K Hampton; A Esack; R C Peatfield; Peter J Grant
Elevation of plasma vasopressin in spontaneous migraine.
Cephalalgia : an international journal of headache 1991;11(6):249-50.
1991: Peter J Grant; K K Hampton; John Primrose; J A Davies; C R Prentice
Vasopressin and haemostatic responses to inguinal hernia repair under local anaesthesia.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1991;2(5):647-50.
1991: K K Hampton; Peter J Grant; John Primrose; H G Dean; J A Davies; C R Prentice
Haemostatic responses and vasopressin release during colonoscopy in man.
Clinical science (London, England : 1979) 1991;81(2):257-60.
1991: Peter J Grant
The effects of metformin on the fibrinolytic system in diabetic and non-diabetic subjects.
Diabète & métabolisme 1991;17(1 Pt 2):168-73.
1991: Peter J Grant; MH Stickland; N A Booth; C R Prentice
Metformin causes a reduction in basal and post-venous occlusion plasminogen activator inhibitor-1 in type 2 diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association 1991;8(4):361-5.
1991: S H Ibbotson; Peter J Grant; R Kerry; V S Findlay; C R Prentice
The influence of infusions of 1-desamino-8-D-arginine vasopressin (DDAVP) in vivo on the anticoagulant effect of recombinant hirudin (CGP39393) in vitro.
Thrombosis and haemostasis 1991;65(1):64-6.
1990: K K Hampton; Peter J Grant; M Boothby; H G Dean; J A Davies; C R Prentice
The effect of modified electroconvulsive therapy on vasopressin release and haemostasis in man.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1990;1(3):293-7.
1990: Peter J Grant
Hormonal regulation of the acute haemostatic response to stress.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1990;1(3):299-306.
1990: Peter J Grant; R L Medcalf
Hormonal regulation of haemostasis and the molecular biology of the fibrinolytic system.
Clinical science (London, England : 1979) 1990;78(1):3-11.
1989: P G Wiles; K K Hampton; Peter J Grant; J A Davies
Lithium therapy does not prevent the effects of vasopressin on skin microvessels in man.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1989;21(9):531-2.
1989: H Hariman; Peter J Grant; J R Hughes; N A Booth; J A Davies; C R Prentice
Effect of physiological concentrations of vasopressin on components of the fibrinolytic system.
Thrombosis and haemostasis 1989;61(2):298-300.
1989: Peter J Grant; MH Stickland; A F Bristow; R F Clarke; J K Wales
Insulin increases plasma somatomedin C (IGF-1) concentrations in adult type 1 diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association 1989;6(3):245-8.
1988: Peter J Grant; MH Stickland; P G Wiles; P J Gaffney; J A Davies; C R Prentice
Acute changes in blood glucose concentration do not promote thrombin generation or fibrin breakdown in type 1 diabetes.
Diabetic medicine : a journal of the British Diabetic Association 1988;5(9):867-70.
1988: J Wilson; Peter J Grant; J A Davies; M Boothby; P J Gaffney; C R Prentice
The relationship between plasma vasopressin and changes in coagulation and fibrinolysis during hip surgery.
Thrombosis research 1988;51(4):439-45.
1988: Peter J Grant; MH Stickland; J A Davies; C R Prentice
Effect of controlled hyperglycaemia on factor VIII concentrations in insulin dependent diabetes mellitus.
Thrombosis research 1988;50(1):157-62.
1988: R G Jones; Peter J Grant; D Brown; MH Stickland; P G Wiles
A rise in the plasma activities of hepatic enzymes is not a common consequence of hypoglycaemia.
Diabetic medicine : a journal of the British Diabetic Association 1988;5(3):253-5.
1988: R C Peatfield; K K Hampton; Peter J Grant
Plasma vasopressin levels in induced migraine attacks.
Cephalalgia : an international journal of headache 1988;8(1):55-7.
1988: P G Wiles; Peter J Grant; MH Stickland; H G Dean; J K Wales; J A Davies
Regional variation in skin blood flow response to hypoglycaemia in type 1 (insulin-dependent) diabetic patients without complications.
Diabetologia 1988;31(2):98-102.
1987: Peter J Grant; MH Stickland; P G Wiles; J A Davies; J K Wales; C R Prentice
Hormonal control of haemostasis during hypoglycaemia in diabetes mellitus.
Thrombosis and haemostasis 1987;57(3):341-4.
1987: Peter J Grant; P G Wiles; H G Dean; J A Davies; C R Prentice
The physiological effects of vasopressin on haemostasis are not mediated by catecholamine release.
Thrombosis research 1987;45(6):839-43.